VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Mastercard Incorporated vs Novo Nordisk A/S
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Mastercard Incorporated
MA · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Mastercard Incorporated's moat claims, evidence, and risks.
View MA analysisNovo Nordisk A/S
NOVOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Novo Nordisk A/S's moat claims, evidence, and risks.
View NOVOB analysisComparison highlights
- Moat score gap: Novo Nordisk A/S leads (85 / 100 vs 77 / 100 for Mastercard Incorporated).
- Segment focus: Mastercard Incorporated has 2 segments (61.5% in Payment Network); Novo Nordisk A/S has 3 segments (71.1% in Diabetes care).
- Moat breadth: Mastercard Incorporated has 6 moat types across 3 domains; Novo Nordisk A/S has 5 across 3.
Primary market context
Mastercard Incorporated
Payment Network
Four-party card payment network (switching, acceptance, and network-related services)
Global
Issuers, acquirers, merchants, account holders
Network operator (authorization, clearing, settlement) and rules/standards steward
61.5%
Novo Nordisk A/S
Diabetes care
Diabetes pharmaceuticals (GLP-1 for type 2 diabetes, insulin, and related therapies)
Global
Payers/providers and patients (via wholesalers/pharmacies/hospitals)
Originator pharma (R&D, regulatory, manufacturing, commercialization)
71.1%
Side-by-side metrics
Moat coverage
Shared moat types
Mastercard Incorporated strengths
Novo Nordisk A/S strengths
Segment mix
Mastercard Incorporated segments
Full profile >Payment Network
Oligopoly
Value-Added Services and Solutions
Competitive
Novo Nordisk A/S segments
Full profile >Diabetes care
Oligopoly
Obesity care
Duopoly
Rare disease
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.